Private Market View

Hemab Therapeutics Holdings

Drug Discovery · Cambridge, MA · Founded 2019 · In IPO Registration

PA Mark · $/share
$29
Sep 2026
Implied valuation
$386.9M
Total raised
$355.1M
Last round
Later Stage VC (Series C)
Oct 2025
Cap table — not yet on record

Hemab Therapeutics Holdings's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 12 names
  • ·Watchlist + deal alerts for Hemab Therapeutics Holdings
Create free account
No card required

Frequently asked

Where does Hemab Therapeutics Holdings's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Hemab Therapeutics Holdings's 2 recorded funding rounds.